Literature DB >> 33296659

Regulatory T Cells Support Breast Cancer Progression by Opposing IFN-γ-Dependent Functional Reprogramming of Myeloid Cells.

Nicholas M Clark1, Leandro M Martinez2, Steven Murdock2, James T deLigio2, Amy L Olex3, Comfort Effi2, Mikhail G Dozmorov4, Paula D Bos5.   

Abstract

Regulatory T (Treg) cell infiltration of solid tumors often correlates with poor prognosis, but their tumor-suppressive function lacks mechanistic understanding. Through a combination of transgenic mice, cell fate mapping, adoptive transfer, and co-injection strategies, we demonstrate that Treg cell ablation-dependent anti-tumor effects in murine breast cancer require intratumoral recruitment of CCR2+ inflammatory monocytes, which primarily differentiate into tumor-associated macrophages (TAMs), and lead to reprogramming of their function in an IFN-γ-dependent manner. Furthermore, transcriptomic signatures from murine TAMs in Treg cell-ablated conditions correlate with increased overall survival in human breast cancer. Our studies highlight the strong myeloid dependency of breast cancer and provide the basis for the development of therapeutic strategies based on manipulation of the IFN-γ signaling pathway in monocytes.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  breast cancer; interferon gamma; monocytes; regulatory T cells; tumor-associated macrophages

Year:  2020        PMID: 33296659      PMCID: PMC7811278          DOI: 10.1016/j.celrep.2020.108482

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  57 in total

1.  Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity.

Authors:  Stefani Spranger; Riyue Bao; Thomas F Gajewski
Journal:  Nature       Date:  2015-05-11       Impact factor: 49.962

2.  Studies in a tumor spectrum. I. Comparison of the action of methylbis (2-chloroethyl)amine and 3-bis(2-chloroethyl)aminomethyl-4-methoxymethyl -5-hydroxy-6-methylpyridine on the growth of a variety of mouse and rat tumors.

Authors:  K SUGIURA; C C STOCK
Journal:  Cancer       Date:  1952-03       Impact factor: 6.860

Review 3.  Regulatory T cells: mechanisms of differentiation and function.

Authors:  Steven Z Josefowicz; Li-Fan Lu; Alexander Y Rudensky
Journal:  Annu Rev Immunol       Date:  2012-01-06       Impact factor: 28.527

4.  The value of estrogen and progesterone receptors in the treatment of breast cancer.

Authors:  C K Osborne; M G Yochmowitz; W A Knight; W L McGuire
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

5.  Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment.

Authors:  Elham Azizi; Ambrose J Carr; George Plitas; Andrew E Cornish; Catherine Konopacki; Sandhya Prabhakaran; Juozas Nainys; Kenmin Wu; Vaidotas Kiseliovas; Manu Setty; Kristy Choi; Rachel M Fromme; Phuong Dao; Peter T McKenney; Ruby C Wasti; Krishna Kadaveru; Linas Mazutis; Alexander Y Rudensky; Dana Pe'er
Journal:  Cell       Date:  2018-06-28       Impact factor: 41.582

6.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome.

Authors:  Bo Li; Colin N Dewey
Journal:  BMC Bioinformatics       Date:  2011-08-04       Impact factor: 3.307

7.  IFNγ signaling endows DCs with the capacity to control type I inflammation during parasitic infection through promoting T-bet+ regulatory T cells.

Authors:  Hyang-Mi Lee; Anne Fleige; Ruth Forman; Sunglim Cho; Aly Azeem Khan; Ling-Li Lin; Duc T Nguyen; Aisling O'Hara-Hall; Zhinan Yin; Christopher A Hunter; Werner Muller; Li-Fan Lu
Journal:  PLoS Pathog       Date:  2015-02-06       Impact factor: 6.823

8.  Cellular backpacks for macrophage immunotherapy.

Authors:  C Wyatt Shields; Michael A Evans; Lily Li-Wen Wang; Neil Baugh; Siddharth Iyer; Debra Wu; Zongmin Zhao; Anusha Pusuluri; Anvay Ukidve; Daniel C Pan; Samir Mitragotri
Journal:  Sci Adv       Date:  2020-04-29       Impact factor: 14.136

9.  Comprehensive molecular portraits of human breast tumours.

Authors: 
Journal:  Nature       Date:  2012-09-23       Impact factor: 49.962

10.  TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data.

Authors:  Antonio Colaprico; Tiago C Silva; Catharina Olsen; Luciano Garofano; Claudia Cava; Davide Garolini; Thais S Sabedot; Tathiane M Malta; Stefano M Pagnotta; Isabella Castiglioni; Michele Ceccarelli; Gianluca Bontempi; Houtan Noushmehr
Journal:  Nucleic Acids Res       Date:  2015-12-23       Impact factor: 16.971

View more
  7 in total

1.  Efficacy of ifosfamide combined with liposome doxorubicin on osteosarcoma and its effects on serum IL-10, TNF-α, and IFN-γ in patients with osteosarcoma.

Authors:  Guilin Huang; Sha Hua; Heming Liu; Haizhen Zhou; Xiujin Chen; Zhichou Wang; Wenxing Yu
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

2.  Activating a collaborative innate-adaptive immune response to control metastasis.

Authors:  Lijuan Sun; Tim Kees; Ana Santos Almeida; Bodu Liu; Xue-Yan He; David Ng; Xiao Han; David L Spector; Iain A McNeish; Phyllis Gimotty; Sylvia Adams; Mikala Egeblad
Journal:  Cancer Cell       Date:  2021-09-02       Impact factor: 38.585

3.  The Inhibitory Effect and Mechanism of Ferula akitschkensis Volatile Oil on Gastric Cancer.

Authors:  Rong Han; Yun Sun; Ruoting Ma; Dexi Wang; Jianan Sun; Shengjun Zhao; Haiying Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-29       Impact factor: 2.629

4.  Immunologically "cold" triple negative breast cancers engraft at a higher rate in patient derived xenografts.

Authors:  Varduhi Petrosyan; Lacey E Dobrolecki; Emily L LaPlante; Ramakrishnan Rajaram Srinivasan; Matthew H Bailey; Alana L Welm; Bryan E Welm; Michael T Lewis; Aleksandar Milosavljevic
Journal:  NPJ Breast Cancer       Date:  2022-09-10

5.  Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer.

Authors:  Natalia Palazón-Carrión; Carlos Jiménez-Cortegana; M Luisa Sánchez-León; Fernando Henao-Carrasco; Esteban Nogales-Fernández; Massimo Chiesa; Rosalía Caballero; Federico Rojo; María-Adoración Nieto-García; Víctor Sánchez-Margalet; Luis de la Cruz-Merino
Journal:  Sci Rep       Date:  2021-07-13       Impact factor: 4.379

6.  N-cadherin inhibitor creates a microenvironment that protect TILs from immune checkpoints and Treg cells.

Authors:  Yi Sun; Jun Jing; Huan Xu; Lingfan Xu; Hailiang Hu; Cai Tang; Shengzhuo Liu; Qiang Wei; Ruiqi Duan; Ju Guo; Lu Yang
Journal:  J Immunother Cancer       Date:  2021-03       Impact factor: 13.751

Review 7.  Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of ER+ Breast Cancers.

Authors:  Linda A Schuler; Fern E Murdoch
Journal:  Cancers (Basel)       Date:  2021-07-24       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.